-
Mashup Score: 1Judge halts some NIH cuts after 22 states sue - 9 hour(s) ago
A federal court in Massachusetts temporarily blocked the Trump administration’s new cap on indirect cost reimbursements for NIH grant recipients within the 22 states that are challenging it.
Source: endpts.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 2Net Zero is not enough: ratcheting ambition for sustainable health systems through Reduce and Support - 27 day(s) ago
Net Zero is the dominant framework for organising health system decarbonisation. Yet throughout Net Zero’s rise to prominence, greenhouse gas emissions have remained on a dangerous trajectory. In this analysis, we synthesise strands of Net Zero critique from the climate policy literature, examine their implications for health systems and briefly present an alternative framework for decarbonisation. We begin by reviewing three families of Net Zero critique which have, to date, received little attention in the sustainable healthcare space: unambitious and inequitable pledges, accounting failures, and structural problems with the framework itself. Together, these critiques challenge the idea that the Net Zero agenda is best positioned to deliver upon the Paris Agreement commitment to limit temperature rise to below 1.5°C–2°C. We then consider how each challenge manifests in the health sector with examples from state and non-state actors. Finally, we briefly introduce an alternative ‘reduc
Source: gh.bmj.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 1SMDM Connect - 1 month(s) ago
View colleagues’ CVs and add your own SMDM Connect is the networking resource for SMDM members and event attendees. If you are a member or attendee of SMDM, please log in with your email and personally created password used in the online store. Interested in becoming involved in SMDM? Create an account to become a member and register for events: Click
Source: connect.smdm.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 2
What Is the issue? Data on trends in the pharmaceutical market remain limited. We offer an annual update on estimated drug purchases in Canada and highlight key factors that could impact future spending. What Did We do? We conducted a retrospective time-series analysis of annual estimated drug purchases across Canada between 2001 and 2023 using IQVIA’s Canadian Drugstore and Hospital Purchases Audit. We calculated total estimated drug purchases and relative percentage change annually, stratified by sector (retail and hospital), and forecast annual spending to 2025. What Did We Find? Total estimated drug purchases for 2023 were approximately $43.5 billion, 13.7% higher than in 2022. Overall, expenditure on the top 25 high-cost drugs accounted for 32.5% and 53.3% of total spending in the retail and hospital sectors, respectively. Pharmaceutical spending has grown over the past 2 decades, with an annual average growth of 5.8% and 8.2% in the retail and hospital sectors, respectively. Drug
Source: www.canjhealthtechnol.caCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 0Should NICE’s cost-effectiveness thresholds change? - 2 month(s) ago
We explore the ongoing debate around NICE’s cost-effectiveness thresholds and what the future holds. Cost-effectiveness thresholds play a vital role in healthcare decision-making, helping to ensure that NHS resources are used efficiently and fairly. As NICE’s programme director for medicines evaluation, I explore some of the ongoing discussions around this topic and explain why NICE uses its current thresholds. At NICE, we’ re tasked with ensuring that the NHS uses its finite budget effectively. Any new
Source: www.nice.org.ukCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 14EJM - Econ Job Market - 3 month(s) ago
The automated language-translation service on econjobmarlet.org is provided free by Google Translate, a third party service. Google is wholly responsible for the tra nslation service. Econ Job Market Inc. does not guarantee or warrant the reliability, accuracy, or completeness of any translated text. Before acting on any translated text, you should verify its fidelity in relation to the original text shown on econjobmarlet.org. Advertiser: Business School, Imperial College London Position type(s):
Source: econjobmarket.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 2Payments by Drug and Medical Device Manufacturers to US Peer Reviewers of Major Medical Journals - 4 month(s) ago
This study characterizes payments by drug and medical device manufacturers to US peer reviewers of major medical journals.
Source: jamanetwork.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 5Estimating Costs in Beremagene Geperpavec for Dystrophic Epidermolysis Bullosa—Reply - 5 month(s) ago
In Reply Chen and colleagues raise 2 important points in response to our analysis of beremagene geperpavec (B-VEC) therapy1: the high costs of therapy may be offset by reductions in other health care costs, and cost-effectiveness analysis (CEA) would help assess the value of B-VEC therapy.
Source: jamanetwork.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 0Greenhouse Gas Emissions and Costs of Inhaler Devices in the US - 6 month(s) ago
This study assesses mean emissions and costs and estimated total yearly emissions and costs for US-branded inhalers prescribed to Medicare Part D and Medicaid beneficiaries.
Source: jamanetwork.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 4Tanker traffic increases tenfold in B.C.'s Burrard Inlet following Trans Mountain pipeline expansion | CBC News - 6 month(s) ago
Data collected by a Simon Fraser University professor, which has been corroborated by Trans Mountain, shows that tanker traffic in Vancouver’s Burrard Inlet has increased tenfold since the company’s expanded pipeline came online this summer.
Source: www.cbc.caCategories: General Medicine News, Hem/OncsTweet
"Judge halts some NIH cuts after 22 states sue" via @endpts @Nicole_DeFeudis https://t.co/Ga3tJNqzW9